CRNX - Crinetics Pharmaceuticals
Earnings Results

Crinetics Pharmaceuticals ( $CRNX )

Recent earnings result

No new results yet...

Join our discord chatroom to get notified as soon as its out.
Next ER estimate scheduled to release on May 11, 2020

Events & Presentations

Crinetics Pharmaceuticals ACROBAT Edge Phase 2 Interim Results and Corporate Update Conference Call

Supporting docs

  1. Listen to webcast
  2. PDF document

Top Stories (CRNX)

Events & Annual meetings

Title Date Webcast
Crinetics Pharmaceuticals ACROBAT Edge Phase 2 Interim Results and Corporate Update Conference Call Apr 7, 2020 at 8:00 AM EDT edge.media-server.com webcast
ir.crinetics.com PDF
9th Annual SVB Leerink Global Healthcare Conferenc Feb 26, 2020 at 1:30 PM EST wsw.com webcast
J.P. Morgan Healthcare Conference Jan 15, 2020 at 3:00 PM PST jpmorgan.metameetings.net webcast





Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. We have assembled a seasoned team with extensive expertise in drug discovery and development in endocrine G-protein coupled receptors (GPCRs) and built a highly productive drug discovery organization.


Disclaimer:

The Content is made available for informational purposes only. The Content may not be complete and may be subject to change.
The Content is provided without any warranty of any kind, either express or implied.
We have collected the events here to help investors easily find the informations they need.
These are manually collected by our researchers directly from Official IR pages and not third party sources.

Recent results

Books we are reading